← Back to Clinical Trials
Recruiting NCT07041034

NCT07041034 SUNAM Protocol for Managing BPSD

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07041034
Status Recruiting
Phase
Sponsor Mackay Medical College
Condition Dementia
Study Type INTERVENTIONAL
Enrollment 120 participants
Start Date 2025-12-20
Primary Completion 2026-12-30

Eligibility & Interventions

Sex All sexes
Min Age 65 Years
Max Age 110 Years
Study Type INTERVENTIONAL
Interventions
Active Comparator GroupExperimental Group

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 120 participants in total. It began in 2025-12-20 with a primary completion date of 2026-12-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study evaluates the effectiveness of the Systematic Unmet Needs Assessment and Management (SUNAM) Protocol, an algorithm-based intervention developed from the unmet needs theory of BPSD, in reducing Behavioral and Psychological Symptoms of Dementia (BPSD) among institutionalized residents. Both the experimental and control groups received 100 minutes of BPSD foundational education and 100 minutes of VR simulation training. The experimental group received an additional 150 minutes of SUNAM protocol training. The study aims to determine whether integrating SUNAM into caregiver training enhances BPSD assessment, management, and reduction by addressing unmet needs.

Eligibility Criteria

Inclusion Criteria: * Diagnosed with dementia or documented as having dementia in medical records. * Currently residing in the long-term care facility. Exclusion Criteria: * Diagnosed with schizophrenia. * The resident's legal representative does not provide consent for participation.

Contact & Investigator

Central Contact

Yi-Heng Chen, PhD

✉ yiheng@mmc.edu.tw

📞 +886-2-26360303 Ext. 1320

Principal Investigator

Yi-Heng C, PhD

PRINCIPAL INVESTIGATOR

Mackay Medical University

Frequently Asked Questions

Who can join the NCT07041034 clinical trial?

This trial is open to participants of all sexes, aged 65 Years or older, up to 110 Years, studying Dementia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07041034 currently recruiting?

Yes, NCT07041034 is actively recruiting participants. Contact the research team at yiheng@mmc.edu.tw for enrollment information.

Where is the NCT07041034 trial being conducted?

This trial is being conducted at New Taipei City, Taiwan, New Taipei City, Taiwan.

Who is sponsoring the NCT07041034 clinical trial?

NCT07041034 is sponsored by Mackay Medical College. The principal investigator is Yi-Heng C, PhD at Mackay Medical University. The trial plans to enroll 120 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology